Medically Supervised Weight Loss in Miami: The 911 Treatment

A lipotropic injection is a compounded blend. The core is MIC: methionine, an essential amino acid; inositol, a sugar alcohol involved in cell signaling; and choline, a nutrient central to how the liver packages and exports fat. Most clinics, including ours, add vitamin B12, which is why the shot is sometimes called MIC B12.

Choline deficiency causes fat to accumulate in the liver, and methionine participates in methylation pathways tied to fat transport. The marketing leap is to say that injecting these compounds makes your body burn stored fat.

That FDA status (see FAQ for what it means for formulation and dosing) carries through to the research itself. The published research is thin: small trials, a median sample size in the dozens, and a substantial share funded by clinics that sell the injections. In the twelve week B12 comparison, the injection group reported better energy and mood but no difference in objective metabolic markers. The Obesity Medicine Association’s guidance does not list B12 or MIC injections among evidence based pharmacotherapies for obesity. Any clinic in Miami describing them as a fat burning shot is describing something the literature does not support.

Three honest reasons. They are low risk in appropriately screened patients. B12 status is genuinely worth addressing in some patients, particularly those on metformin, on long term acid suppression, following restrictive diets, or with absorption problems, a clinical reason distinct from any weight claim. And the scheduled visit does something the literature does support: regular contact with a clinical team and consistent measurement are among the few reliably useful ingredients in weight management.

None of that makes the injection the mechanism. The plan is the mechanism.

GLP-1 receptor agonists such as semaglutide and tirzepatide are FDA approved medications with large randomized trials behind them, real efficacy and real side effects, and they require a prescriber who manages dosing and monitors tolerance. The 911 Treatment does not include them.

If you were hoping for a GLP-1 under another name, you should know before you book that you will not receive one here.

And if a GLP-1 is what your situation clinically calls for, you should be evaluated by a clinician who prescribes and manages them, not talked into something else.

Yes, a supervised program can help you hold your result, and this has become one of the most common reasons people contact us. It is not about replacing the medication. It is the things the medication was never going to do: a protein target, resistance training you actually perform, a realistic maintenance calorie level, and follow up during the months when regain happens.

That structure matters because of what happens once you come off. Appetite returns toward baseline while your maintenance calorie requirement is lower than it was, and that gap is where regain lives. The second factor is body composition: in the published trials roughly a quarter of the weight lost on GLP-1 medications is lean tissue, and the proportion appears to differ between medications. Muscle is metabolically active, so losing it lowers the calorie requirement further and makes maintenance harder.

National survey data puts the share of US adults who have used a GLP-1 medication at around one in eight, and many are now tapering off.

Loose skin after significant weight loss is structural. Elastic fibers that stretched over years do not always retract, and no injection, supplement, diet or wellness program tightens them. That is a contouring conversation, not a weight loss one, and we cover it on our page about the body after weight loss.

Pregnancy or breastfeeding, kidney disease or renal insufficiency, and a known sensitivity to any component (cobalt or B12 hypersensitivity, methionine sensitivity or a sulfa allergy) rule this program out. Liver disease, cardiac conditions and your full medication list need to be on the table at evaluation regardless.

Side effects are generally mild and the FAQ below has the full list, injection site soreness and transient nausea are the most commonly reported, but rash, hives, swelling or difficulty breathing is an immediate stop and seek care situation.

If you have an active eating disorder, a weight loss program is not the right setting and specialized care is.

How many pounds you will lose, that the injection burns fat, or a closed package price before anyone has evaluated you. What we will do is track your numbers and change the plan when the numbers say it is not working.

The program starts with an evaluation, not with an injection. Contact us to book, and mention if you are taking or recently stopped a GLP-1, because that changes how the first visit is structured.